New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma

Citation

Carlino, M, Kwan, V, Miller, D et al. 2015, 'New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma', Journal of Clinical Oncology, vol. 33, no. 11, pp. e52-e56.

Year

2015

ANU Authors

Fields of Research

  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)

Updated:  28 January 2023 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers